Recently, SDIC Chuangyuan Investment Management Co., Ltd. made a strategic investment in Tianmei Times Scientific Instruments Co., Ltd., a leading domestic enterprise in high-end scientific research instruments. This investment aims to support the company in further strengthening its R&D and production capabilities, expanding its global market layout, and promoting the development of China's high-end scientific research instrument industry. As core tools for scientific research and technological innovation, the global high-end scientific research instrument market has long been monopolized by overseas multinational giants. However, with the rise of domestic enterprises, this pattern is gradually changing. This enterprise, rooted in Shanghai for 30 years, has quietly become an "invisible champion" in China's scientific instrument field, holding nearly 70% of the global market share in high-end fluorescence spectroscopy. **The Light of Scientific Research Instruments** Over the years, Tianmei Group has always focused on key fields such as spectroscopy, chromatography-mass spectrometry, and life science laboratory equipment. It has gradually built a global system through two important approaches: internal independent research and overseas mergers and acquisitions. Internally, the R&D team continues to delve into innovation and overcome technical difficulties; externally, it actively conducts overseas mergers and acquisitions to absorb advanced technologies and experience. Through these efforts, Tianmei Group has successfully created 7 independent product brands, including Edinburgh Instruments, Scion, Isotopx, Dynamica, Froilabo, Precisa, etc. These brands have their own characteristics and show strong competitiveness in different细分领域. In terms of R&D and production layout, Tianmei Group has a clear plan. It has established major R&D centers in Shanghai, China, Edinburgh, UK, and other places, gathering global scientific research talents to provide strong support for product technical upgrading. At the same time, it has built multiple production bases in China and Europe to ensure efficient production and supply of products. The company's products have an extremely wide range of applications. In the biomedical field, its equipment assists in new drug research and development and disease diagnosis; in the new energy field, it provides support for battery research and performance testing; in the new materials field, it helps scientists explore the properties of new materials. These products serve customers worldwide and meet the needs of different industries. It is worth mentioning that some of Tianmei Group's products have reached world-leading levels. Fluorescence spectroscopy, gas chromatography, isotope mass spectrometry, high-precision electronic balances and other products have won a good reputation in the international market with their excellent performance and stable quality, laying a solid foundation for the group's sustainable development. **The Road of Counterattack through Mergers and Acquisitions** In fact, the development path of Tianmei Group has been full of ups and downs. In 2005, China's high-end scientific instrument market was highly monopolized by European, American and Japanese enterprises, which occupied 90% of the market share, and the domestic industrial chain was almost blank. It was heavily dependent on foreign countries in terms of core technologies, components and talents. This made it extremely difficult for domestic enterprises to develop in the field of high-end scientific instruments, facing enormous challenges. In 2009, Tianmei Group made a strategically significant decision to acquire Froilabo, a century-old French laboratory temperature control enterprise founded in 1918. This move opened Tianmei's "snake swallowing elephant" - style international development path and embarked on China's journey of global breakthrough in instruments. In the following decade, Tianmei successively brought enterprises such as Britain's Edinburgh Spectroscopy Instruments, Switzerland's Precisa Weighing Instruments, Germany's Bruker's Chromatography-Mass Spectrometry Instruments, and Britain's high-end Isotope Mass Spectrometers under its umbrella, continuously expanding its business territory. Tianmei Group adopted the development path of "introduction - digestion - absorption - re-innovation" to quickly fill the domestic technical gap. Nowadays, the localization rate of products transferred to domestic production has reached more than 85%. This achievement is inseparable from the group's unremitting efforts in technological research and development and innovation. Through in-depth research and improvement of imported technologies, it has realized the localized upgrading of technologies. After acquiring overseas enterprises, Tianmei Group transferred mature overseas technologies to domestic production and gradually promoted the localization of the supply chain. This move not only effectively reduced production costs but also built an independently controllable industrial system. By mastering core technologies and key links, it has improved the enterprise's competitiveness and risk resistance. Meanwhile, products such as electronic balances, chromatography, spectroscopy, biological safety cabinets, and high-speed refrigerated centrifuges produced by Tianmei Group in Shanghai, China, have obtained certifications from European and American countries and been successfully sold to many overseas countries. At present, it has formed a sales network covering 90 countries, realizing the transformation from technology introduction to product export and gaining a foothold in the international market. **A New Three-Step Blueprint** With the country vigorously promoting the localization substitution of scientific instruments, Tianmei Group has ushered in important development opportunities. In this context, Tianmei has actively participated in and led the drafting of a number of industry national standards. The formulation of these standards has not only standardized the development of the industry but also greatly improved the competitiveness of domestic instruments in the global market. The changes in the market are now very obvious. A responsible person for enterprise sales showed BYD's acceptance report and sighed, "In the past, customers would ask if there were similar products of international brands as soon as they opened their mouths, but now they will carefully compare our technical parameters." BYD has adopted Tianmei Group's balance moisture meters and other products on its battery testing lines. After replacing imported products, the cost has been reduced by 60%, which fully reflects the advantages of Tianmei's products. Previously, Tianmei Group formulated a "three-step" plan to break through technical barriers. In 2024, Tianmei plans to complete the localization substitution of 5 imported instruments, focusing on overcoming "bottleneck" components such as ion sources, quadrupoles for mass spectrometry, and high-precision electronic flow sensors. This move will further enhance the independent controllability of domestic instruments and reduce dependence on imported products. This year, Tianmei Group will jointly develop quantum sensing technology with European R&D centers, aiming for international leading accuracy. Quantum sensing technology is of great value in scientific research and industrial applications. Through cooperation with European R&D centers, Tianmei is expected to make important breakthroughs in this field and enhance its technical strength. By 2026, Tianmei Group will lay out in-situ detection and intelligent laboratory systems, promoting the transformation of instruments from "tools" to "solutions". In the future, Tianmei Group will continue to increase investment in independent innovation, deepen global collaborative cooperation, and actively lay out emerging fields. Through these measures, it will continuously forge the core competitiveness of the enterprise, make greater contributions to the development of domestic scientific instruments, and show stronger strength in the global market.